# SORRENTO THERAPEUTICS INC (SRNE)

> SORRENTO THERAPEUTICS INC (SRNE) trades at $0.0003 (+0.00%) as of 3:31:53 PM EST on Nov 13, 2026, -40.00% over the past month, with 29.6 days to cover in short interest.

Canonical: https://massive.com/quote/srne
Data as of: 2026-11-13T20:31:53.547Z (15-minute delayed)
Source: Massive (https://massive.com/docs/llms.txt)

## Price

**$0.0003** +0.00 (+0.00%)
As of 3:31:53 PM EST on Nov 13, 2026 · 15-minute delayed
OTC Link · USD

## Stock performance

How SORRENTO THERAPEUTICS INC (SRNE) stock has performed from one day to one year, with its 52-week range.

| Period | Return |
| --- | --- |
| 1D | +0.00% |
| 1W | +0.00% |
| 1M | -40.00% |
| YTD | -88.46% |
| 1Y | -95.38% |
| 52-wk range | $0.00 – $0.01 |

From daily closes through Nov 13, 2026.

## Key statistics

Today's trading snapshot for SRNE: day range, open, previous close, volume and market cap.

| Measure | Value |
| --- | --- |
| Day range | $0.00 – $0.00 |
| Open | $0.00 |
| Prev close | $0.00 |
| Volume | 69.29K |
| Market cap | — |
| Shares out | — |

## Insider trading

[SORRENTO THERAPEUTICS INC (SRNE) insider trading](https://massive.com/quote/srne/insider-trading.md): open-market Form 4 buys and sells by SORRENTO THERAPEUTICS INC insiders over the last 12 months.

## 8-K filings

Material corporate events SORRENTO THERAPEUTICS INC has disclosed to the SEC on Form 8-K.

- Feb 22, 2023 · [Voluntary bankruptcy](https://massive.com/quote/sec-filings/8-k/bankruptcy-filings.md)
  “on February 13, 2023, Sorrento Therapeutics, Inc. ('Sorrento' or the 'Company') and its wholly-owned direct subsidiary, Scintilla Pharmaceuticals, Inc. (together with the Company, the 'Debtors'), commenced voluntary proceedings under Chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the Southern District of Texas”
- Feb 21, 2023 · [Delisting determination](https://massive.com/quote/sec-filings/8-k/delisting-notices.md)
  “the staff of Nasdaq had determined that the Company's common stock will be delisted from Nasdaq. The Delisting Notice indicated that trading of the Company's common stock will be suspended at the opening of business on February 23, 2023 and a Form 25-NSE will be filed with the Securities and Exchange Commission, which will remove the Company's common stock from listing and registration on Nasdaq.”
- Feb 13, 2023 · Material litigation
  “On December 2, 2022, the arbitrator in that arbitration issued an award (the 'Antibody Award') granting contractual damages and pre-award interest in the amounts of $156,829,562 to NantCell and $16,681,521 to NANTibody. On February 7, 2023, the Court granted the Nant Entities' petitions, entered judgment upon the Antibody Award, and ordered Sorrento to pay to the Nant Entities the previously disclosed amounts awarded in the Antibody Award.”
- Feb 13, 2023 · Material litigation
  “In April 2019, the Company filed an action in the Los Angeles Superior Court derivatively on behalf of Immunotherapy NANTibody LLC against NantCell, Inc. and Patrick Soon-Shiong, among others, related to several breaches of the June 11, 2015 Limited Liability Company Agreement. The suit alleges breaches of fiduciary duties and seeks restoration of $90.05 million to the NANTibody capital account.”
- Feb 13, 2023 · [Voluntary bankruptcy](https://massive.com/quote/sec-filings/8-k/bankruptcy-filings.md)
  “On February 13, 2023, Sorrento Therapeutics, Inc. (the "Company") and its wholly-owned direct subsidiary, Scintilla Pharmaceuticals, Inc., commenced voluntary proceedings under Chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the Southern District of Texas (the "Chapter 11 Filings").”

## Dividend history and stock splits

SORRENTO THERAPEUTICS INC's recent dividend payments and stock splits.

### Dividends

No recent dividends.

### Splits

- 1-for-25 · Aug 1, 2013

## SRNE short interest

How heavily SRNE is shorted: shares short, days to cover and average daily volume.

| Measure | Value |
| --- | --- |
| Days to cover | 29.6 |
| Short interest | 3.5M |
| Avg volume | 118.19K |

As of Oct 30, 2026 · reported to FINRA twice monthly.

## SRNE news

The latest news and headlines about SORRENTO THERAPEUTICS INC (SRNE).

- [Scilex Holding Company, Following its Prior Announcement of the Record Date for a Dividend of Preferred Stock, Reiterates Information Previously Provided to Scilex Stockholders Regarding Manipulative and Naked Short Selling of Scilex Common Stock](https://www.globenewswire.com/news-release/2024/10/29/2970573/0/en/Scilex-Holding-Company-Following-its-Prior-Announcement-of-the-Record-Date-for-a-Dividend-of-Preferred-Stock-Reiterates-Information-Previously-Provided-to-Scilex-Stockholders-Regar.html) · GlobeNewswire Inc. · Oct 29, 2024 · positive sentiment
- [By 2034, CAR-T Cell Therapy Market Set to Soar USD 8.7 Billion, at 1.80% CAGR: Prophecy Market Insights](https://www.globenewswire.com/news-release/2024/08/27/2936261/0/en/By-2034-CAR-T-Cell-Therapy-Market-Set-to-Soar-USD-8-7-Billion-at-1-80-CAGR-Prophecy-Market-Insights.html) · GlobeNewswire Inc. · Aug 27, 2024 · positive sentiment
- [Why Sorrento Therapeutics Stock Crashed Today](https://www.fool.com/investing/2023/02/22/why-sorrento-therapeutics-stock-crashed-today/) · The Motley Fool · Feb 22, 2023
- [Why Quoin Pharmaceuticals Shares Are Trading Lower By Over 40%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session](https://www.benzinga.com/news/23/02/31013456/why-quoin-pharmaceuticals-shares-are-trading-lower-by-over-40-here-are-other-stocks-moving-in-wednes) · Benzinga · Feb 22, 2023
- [The stock market is due a bounce after the 697-point selloff in the Dow, says this analyst. Here's why.](https://www.marketwatch.com/story/heres-why-one-technical-analyst-says-the-stock-market-is-due-a-bounce-after-the-697-point-sell-off-in-the-dow-16a577e7) · MarketWatch · Feb 22, 2023

## About SORRENTO THERAPEUTICS INC

SORRENTO THERAPEUTICS INC

| Measure | Value |
| --- | --- |
| Exchange | OTC Link |
| Market | otc |
| Type | CS |
| Currency | USD |

## FAQ

### What is the SORRENTO THERAPEUTICS INC (SRNE) stock price today?

SORRENTO THERAPEUTICS INC (SRNE) is trading at $0.0003 (+0.00% on the day) as of 3:31:53 PM EST on Nov 13, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

### What is SORRENTO THERAPEUTICS INC?

SORRENTO THERAPEUTICS INC

### What is the short interest in SRNE?

As of Oct 30, 2026, SRNE has 3.5M shares short and 29.6 days to cover.

### What exchange is SRNE listed on?

SORRENTO THERAPEUTICS INC (SRNE) trades on OTC Link in USD.

## Live data

Prices here are 15-minute delayed. For real-time SRNE quotes and the full history behind this page, use the Massive API or MCP server:

- `GET https://api.massive.com/v3/snapshot?ticker.any_of=SRNE`

Requests need a Massive API key. API reference for agents: https://massive.com/docs/llms.txt. Connect an AI agent through the Massive MCP server: https://massive.com/docs/ai-tools.

## Related

- [SORRENTO THERAPEUTICS INC (SRNE) insider trading](https://massive.com/quote/srne/insider-trading.md)
- [SEC 8-K events](https://massive.com/quote/sec-filings/8-k.md)
- [Markets overview](https://massive.com/quote/index.md)

Nothing here is investment advice. Data and content are provided for informational purposes under the Massive Terms of Service: https://massive.com/terms
